Table 1 Relationship between dirty necrosis and clinicopathologic features in gastric carcinomas.
From: Prognostic evaluation of dirty necrosis and tumor necrosis in gastric cancers
Clinicopathological features | Dirty necrosis | P value | ||
|---|---|---|---|---|
Absent | Present | |||
Gender | Male | 75 (66.4%) | 47 (63.5%) | 0.754 |
Female | 38 (33.6%) | 27 (36.5%) | ||
Age | < 65 | 52 (46%) | 33 (44.6%) | 0.881 |
≥ 65 | 61 (54%) | 41 (55.4%) | ||
Histologic type | Poorly cohesive | 44 (39.3%) | 4 (5.4%) | < 0.001 |
Non poorly cohesive | 68 (60.7%) | 70 (94.6%) | ||
Size | < 6 cm | 62 (54.9%) | 43 (58.1%) | 0.763 |
≥ 6 cm | 51 (45.1%) | 31 (41.9%) | ||
Tumor grade | 1 | 9 (8.0%) | 16 (21.6%) | < 0.001 |
2 | 24 (21.2%) | 41 (55.4%) | ||
3 | 80 (70.8%) | 17 (23.0%) | ||
pT stage | T1(a-b) | 11 (9.7%) | 10 (13.5%) | 0.084 |
T 2–3 | 47 (41.6%) | 40 (54.1%) | ||
T4(a-b) | 55 (48.7%) | 24 (32.4%) | ||
pN stage | pN 0 | 21 (18.6%) | 23 (31.1%) | < 0.001 |
pN 1–2 | 31 (27.4%) | 30 (40.5%) | ||
pN 3a-b | 61 (54.0%) | 21 (28.4%) | ||
LVI | Absent | 28 (24.8%) | 27 (36.5%) | 0.102 |
Present | 85 (75.2%) | 47 (63.5%) | ||
PNI | Absent | 37 (32.7%) | 37 (50.0%) | 0.022 |
Present | 76 (67.3%) | 37 (50.0%) | ||
TIL | Absent | 111 (98.2%) | 1 (1.4%) | < 0.001 |
Present, sparse | 1 (0.9%) | 37 (50.0%) | ||
Present, prominent | 1 (0.9%) | 36 (48.6%) | ||
HER2 status | Negative | 97 (87.4%) | 56 (76.7%) | 0.071 |
Positive | 14 (12.6%) | 17 (23.3%) | ||
Recurrence | Yes | 26 (23.0%) | 11 (14.9%) | 0.172 |
No | 87 (77.0%) | 63 (85.1%) | ||
Ex status | Yes | 76 (67.3%) | 36 (48.6%) | 0.015 |
No | 37 (32.7%) | 38 (51.4%) | ||
